C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2011
05/19/2011	US20110117117 Novel immunogenic epitopes for immunotherapy
05/19/2011	US20110117116 Nucleic acids encoding a house dust mite allergen, der p iii, and uses therefor
05/19/2011	US20110117112 Sodium channel protein type iii alpha-subunit splice variant
05/19/2011	US20110117111 Microrna-based diagnostic testing and therapies for inflammatory bowel disease and related diseases
05/19/2011	US20110117110 Anti-egfr antibodies and their uses
05/19/2011	US20110117102 Therapeutic uses of inhibitors of RTP801
05/19/2011	US20110117101 Cc chemokine receptor 5 dna, new animal models and therapeutic agents for hiv infection
05/19/2011	US20110117099 Inhibiting staphylococcus epidermidis infections
05/19/2011	US20110117095 Growth factor htter36
05/19/2011	US20110117086 Monoclonal antibodies to progastrin and their uses
05/19/2011	US20110117080 Anti-REG4 Antibodies
05/19/2011	US20110117079 Therapeutic dll4 binding proteins
05/19/2011	US20110117072 Hyperactive variants of the transposase protein of the transposon system sleeping beauty
05/19/2011	US20110117067 Glucanases, Nucleic Acids Encoding Them and Methods for Making and Using Them
05/19/2011	US20110117058 Method of treating genetic disorders
05/19/2011	US20110117017 Peptides with properties of an allosteric antagonist selective for the alpha 1a adrenergic receptor and uses thereof
05/19/2011	US20110117016 Diagnostic compounds
05/19/2011	US20110117011 Neutralizing proprotein convertase subtilisin kexin type 9 (pcsk9) variants and uses thereof
05/19/2011	DE10296990B4 Verwendung eines Biochips zur Diagnose von Sepsis und sepsisähnlichem Syndrom Using a biochip for the diagnosis of sepsis and sepsis-like syndrome
05/19/2011	CA2817495A1 Compositions, methods and uses for stimulating immune responses
05/19/2011	CA2786118A1 Methods for pcr and hla typing using raw blood
05/19/2011	CA2781045A1 Transformant which produces collagen wherein both lysine residue and proline residue are hydroxylated
05/19/2011	CA2780763A1 Factor viii b cell epitope variants having reduced immunogenicity
05/19/2011	CA2780761A1 Factor viii t cell epitope variants having reduced immunogenicity
05/19/2011	CA2780726A1 Method for generation and regulation of ips cells and compositions thereof
05/19/2011	CA2780723A1 Novel double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity
05/19/2011	CA2780563A1 Antisense molecules and methods for treating pathologies
05/19/2011	CA2780542A1 Von willebrand factor (vwf)-containing preparations, and methods, kits, and uses related thereto
05/19/2011	CA2780430A1 Genes differentially expressed by cumulus cells and assays using same to identify pregnancy competent oocytes
05/19/2011	CA2780208A1 Therapeutic and diagnostic applications against trypanosomosis
05/19/2011	CA2780066A1 Non-dna base-containing polynucleotide compositions and their use for the modulation of immune responses
05/19/2011	CA2779988A1 Plants having enhanced yield-related traits and a method for making the same
05/19/2011	CA2779858A1 Multifunctional alleles
05/19/2011	CA2779830A1 Antisense antiviral compound and method for treating influenza viral infection
05/19/2011	CA2779683A1 Anti-c-mpl antibodies
05/19/2011	CA2779293A1 Solution assay and high through-put screen to probe interaction between human cullin-ring ligase complex and hiv-vif protein
05/19/2011	CA2779076A1 Anti-trypanosomiasis vaccines and diagnostics
05/19/2011	CA2778953A1 Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1
05/19/2011	CA2778839A1 Glycosyl transferase from chinese hamster and related methods
05/19/2011	CA2778765A1 Hollow fiber membrane module for use in production of chemical substance, and process for production of chemical substance
05/19/2011	CA2776336A1 Polypeptides having cellobiohydrolase activity and polynucleotides encoding same
05/18/2011	EP2322933A1 Diagnosis of carcinomas
05/18/2011	EP2322670A2 Method for typing and detecting HBV
05/18/2011	EP2322669A2 Method for typing and detecting HBV
05/18/2011	EP2322668A2 Highly conserved gene and its use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes for microorganisms.
05/18/2011	EP2322667A2 Highly conserved gene and its use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes for microorganisms.
05/18/2011	EP2322666A2 Highly conserved gene and its use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes for microorganisms.
05/18/2011	EP2322665A1 MicroRNAs and uses thereof
05/18/2011	EP2322664A1 Methods and sequences for the detection and identification of methicillin-resistant Staphylococcus aureus MREJ type vi strains
05/18/2011	EP2322663A1 Methods and sequences for the detection and identification of methicillin-resistant Staphylococcus aureus MREJ type v strains
05/18/2011	EP2322662A1 MicroRNAs and uses thereof
05/18/2011	EP2322661A1 Methods and sequences for the detection and identification of methicillin-resistant Staphylococcus aureus MREJ type ix strains
05/18/2011	EP2322660A1 MicroRNAs and uses thereof
05/18/2011	EP2322657A1 Methods and sequences to preferentially suppress expression of mutated huntingtin gene.
05/18/2011	EP2322655A1 Methods and sequences for the detection and identification of methicillin-resistant Staphylococcus aureus MREJ type viii strains
05/18/2011	EP2322654A1 MicroRNAs and uses thereof
05/18/2011	EP2322653A1 MicroRNAs and uses thereof
05/18/2011	EP2322652A1 MicroRNAs and uses thereof
05/18/2011	EP2322651A1 MicroRNAs and uses thereof
05/18/2011	EP2322650A1 MicroRNAs and uses thereof
05/18/2011	EP2322649A1 Method for rapid detection and identification of bioagents
05/18/2011	EP2322648A1 RNA aptamers and methods for identifying the same
05/18/2011	EP2322644A1 Methods for producing modified glycoproteins
05/18/2011	EP2322638A1 AAV vectors for in vivo gene therapy of rheumatoid arthritis
05/18/2011	EP2322637A1 Transgenic non-human mammal comprising a polynucleotide encoding human or humanized C5AR
05/18/2011	EP2322636A1 Alpha galactosidase attached to an ER retention signal and its production in plants
05/18/2011	EP2322635A2 Chimeric promoters capable of mediating gene expression in plants upon pathogen infection and uses thereof
05/18/2011	EP2322634A2 Chimeric promoters capable of mediating gene expression in plants upon pathogen infection and uses thereof
05/18/2011	EP2322633A2 Preparation of organisms with faster growth and/or higher yield
05/18/2011	EP2322632A2 Glufosinate tolerant rice
05/18/2011	EP2322631A1 In vivo incorporation of unnatural amino acids
05/18/2011	EP2322630A2 Polypeptides having xylanase activity and polynucleotides encoding same
05/18/2011	EP2322629A2 Novel glyphosate-n-acetyltransferase (GAT) genes
05/18/2011	EP2322628A2 Mutations in the BCR-ABL tyrosine kinase associated with resistance to STI-571
05/18/2011	EP2322627A2 Mutations in the BCR-abl tyrosine kinase associated with resistance to STI-571
05/18/2011	EP2322626A1 HIV-GAG codon-optimised DNA vaccines
05/18/2011	EP2322625A1 Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof
05/18/2011	EP2322624A2 Method for isolation of soluble polypeptides
05/18/2011	EP2322623A2 Method for isolation of soluble polypeptides
05/18/2011	EP2322622A2 Method for isolation of soluble polypeptides
05/18/2011	EP2322621A2 Method for isolation of soluble polypeptides
05/18/2011	EP2322620A2 Analogs of human pancreatic polypeptide and their effects on feeding behaviour
05/18/2011	EP2322619A1 Inhibitors of centrosomal clustering
05/18/2011	EP2322618A1 Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells
05/18/2011	EP2322617A2 Short interfering ribonucleic acid (siRNA) for oral administration
05/18/2011	EP2322616A1 Methods and compositions involving miRNA and miRNA inhibitor molecules
05/18/2011	EP2322615A1 Use of unmethylated CpG oligonucleotides for the treatment of allergy
05/18/2011	EP2322614A1 Recombinational cloning using engineered recombination sites
05/18/2011	EP2322613A1 Reagents and methods for isolation of purified RNA
05/18/2011	EP2322612A1 METHOD FOR PRODUCTION OF cDNA LIBRARY HAVING REDUCED CONTENT OF cDNA CLONE DERIVED FROM HIGHLY EXPRESSED GENE
05/18/2011	EP2322611A1 Method for production of reprogrammed cell using chromosomally unintegrated virus vector
05/18/2011	EP2322610A1 Anti-human clcp1 antibody and use thereof
05/18/2011	EP2322609A1 Hcv/gbv-b chimeric virus
05/18/2011	EP2322608A1 Transfection agent
05/18/2011	EP2322607A1 Novel variant hyprocrea jecorina CBH1 cellulases
05/18/2011	EP2322606A1 Novel variant Hyprocrea jecorina CBH1 cellulases
05/18/2011	EP2322605A2 Terpene synthases
05/18/2011	EP2322601A1 Method of collecting placental stem cells
05/18/2011	EP2322559A2 Neoplasm specific antibodies and uses thereof
05/18/2011	EP2322553A2 Interleukin-17F antibodies and other IL-17F signaling antagonists and uses therefor

1 ... 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 ... 4023